Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 2, 2012, Pages 182-187

  Scarpini, Sylvia ^a   Rouprêt, Morgan ^a,d   Renard Penna, Raphaële ^a   Camparo, Philippe ^b   Cussenot, Olivier ^c,d   Compérat, Eva ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Hôpital d'instruction des armées Val de Grâ ce   (France)

^c HÔPITAL TENON   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Markers; Prognosis; Renal pelvis; Survival; Ureter; Urothelial cell carcinoma

Indexed keywords

AURORA A KINASE; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS CARCINOMA; MALE; NEPHROURETERECTOMY; PRIORITY JOURNAL; RISK FACTOR; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; URETER CARCINOMA; URINARY TRACT; URINARY TRACT CARCINOMA; UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT; VASCULAR TUMOR;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES; UROLOGIC NEOPLASMS;

EID: 84857646349     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.12.003     Document Type: Article

References (31)

1. Comperat E., Bieche I., Dargere D., et al. Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer. Urology 2008, 72:873-877.
2. Comperat E., Camparo P., Haus R., et al. Aurora-A/STK-15 is a predictive factor for recurrent behavior in noninvasive bladder carcinoma: A study of 128 cases of noninvasive neoplasms. Virchows Arch 2007, 450:419-424.
3. Frank I., Cheville J.C., Blute M.L., et al. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement. Cancer 2004, 101:1803-1808.
4. Catto J.W., Azzouzi A.R., Amira N., et al. Distinct patterns of microsatellite instability are seen in tumors of the urinary tract. Oncogene 2003, 22:8699-8706.
5. Roupret M., Catto J., Coulet F., et al. Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma. J Med Genet 2004, 41:e91.
6. Vogelstein B., Kinzler K.W. p53 Function and dysfunction. Cell 1992, 70:523-526.
7. Bartek J., Bartkova J., Vojtesek B., et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 1991, 6:1699-1703.
8. Brown D.C., Gatter K.C. Ki67 protein: The immaculate deception?. Histopathology 2002, 40:2-11.
9. Kamijima S., Tobe T., Suyama T., et al. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter. Int J Urol 2005, 12:941-947.
10. Fromont G., Roupret M., Amira N., et al. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin, and MSH2 expression in upper urinary tract transitional cell carcinoma. Eur Urol 2005, 48:764-770.
11. Habuchi T., Marberger M., Droller M.J., et al. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 2005, 66:64-74.
12. Bischoff J.R., Plowman G.D. The Aurora/Ipl1p kinase family: Regulators of chromosome segregation and cytokinesis. Trends Cell Biol 1999, 9:454-459.
13. Ducat D., Zheng Y. Aurora kinases in spindle assembly and chromosome segregation. Exp Cell Res 2004, 301:60-67.
14. Kawamura K., Moriyama M., Shiba N., et al. Centrosome hyperamplification and chromosomal instability in bladder cancer. Eur Urol 2003, 43:505-515.
15. Fraizer G.C., Diaz M.F., Lee I.L., et al. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Int J Oncol 2004, 25:1631-1639.
16. Sen S., Zhou H., Zhang R.D., et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 2002, 94:1320-1329.
17. Mhawech-Fauceglia P., Fischer G., Beck A., et al. Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma: A retrospective TMA study of 246 patients with long-term follow-up. Eur J Surg Oncol 2006, 32:439-444.
18. Gerdes J., Becker M.H., Key G., et al. Immunohistologic detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992, 168:85-86.
19. Vojtesek B., Bartek J., Midgley C.A., et al. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992, 151:237-244.
20. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients. Urology 1998, 52:594-601.
21. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
22. McCredie M., Stewart J.H., Ford J.M. Analgesics and tobacco as risk factors for cancer of the ureter and renal pelvis. J Urol 1983, 130:28-30.
23. Lin Y.G., Immaneni A., Merritt W.M., et al. Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth. Clin Cancer Res 2008, 14:5437-5446.
24. Munoz J.J., Ellison L.M. Upper tract urothelial neoplasms: Incidence and survival during the last 2 decades. J Urol 2000, 164:1523-1525.
25. Park S., Hong B., Kim C.S., et al. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 2004, 171:621-625.
26. Catto J.W., Yates D.R., Rehman I., et al. Behavior of urothelial carcinoma with respect to anatomical location. J Urol 2007, 177:1715-1720.
27. Lehmann J., Suttmann H., Kovac I., et al. Transitional cell carcinoma of the ureter: Prognostic factors influencing progression and survival. Eur Urol 2007, 51:1281-1288.
28. Zigeuner R., Tsybrovskyy O., Ratschek M., et al. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma. Urology 2004, 63:1079-1083.
29. Kamai T., Takagi K., Asami H., et al. Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter. BJU Int 2000, 86:14-19.
30. Hong B., Park S., Hong J.H., et al. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract. Urology 2005, 65:692-696.
31. Saito K., Kawakami S., Fujii Y., et al. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol 2007, 178:2291-2296.